Evidence-based decision making: Should the general dentist adopt the use of the VELscope for routine screening for oral cancer;Prise de décision fondée sur les données probantes: Le dentiste généraliste devrait-il adopter le VELscope pour le dépistage systématique du cancer de la bouche?

Journal of the Canadian Dental Association

Volumn 73, Issue 7, 2007, Pages 603-606

  Balevi, Ben ^a  

^a Université de la Colombie Britannique ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT;

ADULT; ARTICLE; DECISION MAKING; EVIDENCE BASED MEDICINE; FEMALE; FLUORESCENCE; HUMAN; INSTRUMENTATION; LIGHT; MALE; MASS SCREENING; MIDDLE AGED; MOUTH TUMOR; PATIENT ATTITUDE;

ADULT; DECISION MAKING; EVIDENCE-BASED MEDICINE; FEMALE; FLUORESCENCE; HUMANS; LIGHT; MALE; MASS SCREENING; MIDDLE AGED; MOUTH NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 34848835096     PISSN: 07098936     EISSN: 14882159     Source Type: Journal    
DOI: None     Document Type: Note

References (18)

1. VELscope: the oral cancer screening system. [Site Web de LED Dental Inc., White Rock, C.-B.; 2007]. Disponible à l'URL : www.velscope.com (consulté le 24 juin 2007).
2. Deconinck S, Boeke AJ, van der Waal I, van der Windt DA. Incidence and management of oral conditions in general practice. Br J Gen Pract 2003; 53(487):130-2.
3. FDI policy statement: oral cancer. [Site Web de la Fédé ration dentaire internationale; 1998]. Disponible à l'URL : www.fdiworldental.org/federation/asset s /statement s /ENGLISH/Oral_Cancer/ Oral_Cancer.pdf (consulté le 24 juin 2007).
4. Statistiques canadiennes sur le cancer 2006. Ottawa : Société canadienne du cancer, Institut national du cancer du Canada et Statistique Canada; 2006. Disponible à l'URL : www.cancer.ca/vgn/images/portal/cit_86755361/31/22/935505932cw_2006stats_fr.pdf. pdf (consulté le 31 juillet, 2007).
5. Fast stats: oral cavity and pharynx cancer. [Site Web du National Cancer Institute; 2007]. Disponible à l'URL : seer.cancer.gov/faststats/sites. php? stat=Incidence&site=Oral+Cavity+and+Phar ynx+Cancer&x=20&y=19 (consulté le 24 juin 2007).
6. Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacAulay C. Visualization and other emerging technologies as change markers for oral cancer prevention. Ann N Y Acad Sci 2007; 1098:167-83. Epub 2007 Mar 1.
7. Poh CF, Williams PM, Zhang L, Rosin MP. Attention! - Appel aux dentistes pour le dépistage du cancer de la bouche. J Can Dent Assoc 2006; 72(5):413-6.
8. Welie JV. La dentisterie est-elle une profession? Partie 2. Les marques du professionnalisme. J Can Dent Assoc 2004; 70(9):599-602.
9. Sackett DL, Strauss SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. 2nd ed. London: Churchill Livingstone; 2000.
10. VELscope: studies and clinical papers. [Site Web de LED Dental Inc., White Rock, C.-B.; 2006]. Disponible à l'URL : www.velscope.com/velscope/ studies.php (accessed June 24, 2007).
11. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, and others. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 2007; 29(1):71-6.
12. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, and others. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006; 12(22):6716-22.
13. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, and others. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006; 11(2):024006.
14. Kois JC, Truelove E. Detecting oral cancer: a new technique and case reports. Dent Today 2006; 25(10):94, 96-7.
15. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Boston: Butterworth-Heinemann; 1988.
16. Muir Gray JA. Evidence-based health care: how to make health policy and management decisions. 2nd ed. London: Churchill Livingstone; 2001.
17. Roddam AW, Rimmer J, Nickerson C, Ward AM; NHS Prostate Cancer Risk Management Programme. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem 2006; 43(Pt 1):35-48.
18. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007; 297(9):953-6